1
|
Neamtu I, Ghilan A, Rusu AG, Nita LE, Chiriac VM, Chiriac AP. Design and applications of polymer-like peptides in biomedical nanogels. Expert Opin Drug Deliv 2024; 21:713-734. [PMID: 38916156 DOI: 10.1080/17425247.2024.2364651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2024] [Accepted: 06/03/2024] [Indexed: 06/26/2024]
Abstract
INTRODUCTION Polymer nanogels are among the most promising nanoplatforms for use in biomedical applications. The substantial interest for these drug carriers is to enhance the transportation of bioactive substances, reduce the side effects, and achieve optimal action on the curative sites by targeting delivery and triggering the release of the drugs in a controlled and continuous mode. AREA COVERED The review discusses the opportunities, applications, and challenges of synthetic polypeptide nanogels in biomedicine, with an emphasis on the recent progress in cancer therapy. It is evidenced by the development of polypeptide nanogels for better controlled drug delivery and release, in complex in vivo microenvironments in biomedical applications. EXPERT OPINION Polypeptide nanogels can be developed by choosing the amino acids from the peptide structure that are suitable for the type of application. Using a stimulus - sensitive peptide nanogel, it is possible to obtain the appropriate transport and release of the drug, as well as to achieve desirable therapeutic effects, including safety, specificity, and efficiency. The final system represents an innovative way for local and sustained drug delivery at a specific site of the body.
Collapse
Affiliation(s)
- Iordana Neamtu
- Natural Polymers, Bioactive and Biocompatible Materials Laboratory, Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania
| | - Alina Ghilan
- Natural Polymers, Bioactive and Biocompatible Materials Laboratory, Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania
| | - Alina Gabriela Rusu
- Natural Polymers, Bioactive and Biocompatible Materials Laboratory, Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania
| | - Loredana Elena Nita
- Natural Polymers, Bioactive and Biocompatible Materials Laboratory, Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania
| | - Vlad Mihai Chiriac
- Faculty of Electronics Telecommunications and Information Technology, Gh. Asachi Technical University, Iaşi, Romania
| | - Aurica P Chiriac
- Natural Polymers, Bioactive and Biocompatible Materials Laboratory, Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania
| |
Collapse
|
2
|
Wang T, Chang TMS. Superparamagnetic Artificial Cells PLGA-Fe 3O 4 Micro/Nanocapsules for Cancer Targeted Delivery. Cancers (Basel) 2023; 15:5807. [PMID: 38136352 PMCID: PMC10741498 DOI: 10.3390/cancers15245807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 11/10/2023] [Accepted: 12/04/2023] [Indexed: 12/24/2023] Open
Abstract
Artificial cells have been extensively used in many fields, such as nanomedicine, biotherapy, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, and the COVID-19 vaccine. The unique properties of superparamagnetic Fe3O4 nanoparticles have contributed to increased interest in using superparamagnetic artificial cells (PLGA-Fe3O4 micro/nanocapsules) for targeted therapy. In this review, the preparation methods of Fe3O4 NPs and superparamagnetic artificial cell PLGA-drug-Fe3O4 micro/nanocapsules are discussed. This review also focuses on the recent progress of superparamagnetic PLGA-drug-Fe3O4 micro/nanocapsules as targeted therapeutics. We shall concentrate on the use of superparamagnetic artificial cells in the form of PLGA-drug-Fe3O4 nanocapsules for magnetic hyperthermia/photothermal therapy and cancer therapies, including lung breast cancer and glioblastoma.
Collapse
Affiliation(s)
| | - Thomas Ming Swi Chang
- Artificial Cells and Organs Research Centre, Departments of Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, QC H3G 1Y6, Canada
| |
Collapse
|
3
|
Guzmán E, Ortega F, Rubio RG. Layer-by-Layer Nanoassemblies for Vaccination Purposes. Pharmaceutics 2023; 15:pharmaceutics15051449. [PMID: 37242691 DOI: 10.3390/pharmaceutics15051449] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 05/08/2023] [Accepted: 05/09/2023] [Indexed: 05/28/2023] Open
Abstract
In recent years, the availability of effective vaccines has become a public health challenge due to the proliferation of different pandemic outbreaks which are a risk for the world population health. Therefore, the manufacturing of new formulations providing a robust immune response against specific diseases is of paramount importance. This can be partially faced by introducing vaccination systems based on nanostructured materials, and in particular, nanoassemblies obtained by the Layer-by-Layer (LbL) method. This has emerged, in recent years, as a very promising alternative for the design and optimization of effective vaccination platforms. In particular, the versatility and modularity of the LbL method provide very powerful tools for fabricating functional materials, opening new avenues on the design of different biomedical tools, including very specific vaccination platforms. Moreover, the possibility to control the shape, size, and chemical composition of the supramolecular nanoassemblies obtained by the LbL method offers new opportunities for manufacturing materials which can be administered following specific routes and present very specific targeting. Thus, it will be possible to increase the patient convenience and the efficacy of the vaccination programs. This review presents a general overview on the state of the art of the fabrication of vaccination platforms based on LbL materials, trying to highlight some important advantages offered by these systems.
Collapse
Affiliation(s)
- Eduardo Guzmán
- Departamento de Química Física, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain
- Instituto Pluridisciplinar, Universidad Complutense de Madrid, Paseo Juan XIII, 28040 Madrid, Spain
| | - Francisco Ortega
- Departamento de Química Física, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain
- Instituto Pluridisciplinar, Universidad Complutense de Madrid, Paseo Juan XIII, 28040 Madrid, Spain
| | - Ramón G Rubio
- Departamento de Química Física, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain
| |
Collapse
|
4
|
Luo X, Wu S, Xiao M, Gu H, Zhang H, Chen J, Liu Y, Zhang C, Zhang J. Advances and Prospects of Prolamine Corn Protein Zein as Promising Multifunctional Drug Delivery System for Cancer Treatment. Int J Nanomedicine 2023; 18:2589-2621. [PMID: 37213352 PMCID: PMC10198181 DOI: 10.2147/ijn.s402891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 05/06/2023] [Indexed: 05/23/2023] Open
Abstract
Zein is a type of prolamine protein that is derived from corn, and it has been recognized by the US FDA as one of the safest biological materials available. Zein possesses valuable characteristics that have made it a popular choice for the preparation of drug carriers, which can be administered through various routes to improve the therapeutic effect of antitumor drugs. Additionally, zein contains free hydroxyl and amino groups that offer numerous modification sites, enabling it to be hybridized with other materials to create functionalized drug delivery systems. However, despite its potential, the clinical translation of drug-loaded zein-based carriers remains challenging due to insufficient basic research and relatively strong hydrophobicity. In this paper, we aim to systematically introduce the main interactions between loaded drugs and zein, administration routes, and the functionalization of zein-based antitumor drug delivery systems, in order to demonstrate its development potential and promote their further application. We also provide perspectives and future directions for this promising area of research.
Collapse
Affiliation(s)
- Xi Luo
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
| | - Sudan Wu
- Blood Purification Center, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
| | - Meng Xiao
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
| | - Huan Gu
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
| | - Huan Zhang
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
| | - Jianping Chen
- Lika Shing Faculty of Medicine, School of Chinese Medicine, the University of Hong KOng, Hong Kong, People’s Republic of China
| | - Yang Liu
- Department of Vascular Surgery, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
- Correspondence: Yang Liu, Hospital of Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Jinniu District, Chengdu, Sichuan, People’s Republic of China, Email
| | - Chen Zhang
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
| | - Jinming Zhang
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
- Jinming Zhang, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, No.1166, Liutai Avenue, Wenjiang District, Chengdu, Sichuan, People’s Republic of China, Email
| |
Collapse
|
5
|
Biopolymer coating for particle surface engineering and their biomedical applications. Mater Today Bio 2022; 16:100407. [PMID: 36090610 PMCID: PMC9450159 DOI: 10.1016/j.mtbio.2022.100407] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 07/19/2022] [Accepted: 08/18/2022] [Indexed: 11/20/2022]
Abstract
Surface engineering of particles based on a polymeric coating is of great interest in materials design and applications. Due to the disadvantages of non-biodegradability and undesirable biocompatibility, the application of petroleum-based synthetic polymers coating in the biomedical field has been greatly limited. In addition, there is lack of a universal surface modification method to functionalize particles of different compositions, sizes, shapes, and structures. Thus, it is imperative to develop a versatile biopolymeric coating with good biocompatibility and tunable biodegradability for the preparation of functional particle materials regardless of their surface chemical and physical structures. Recently, the natural polysaccharide polymers (e.g. chitosan and cellulose), polyphenol-based biopolymers (e.g. polydopamine and tannic acid), and proteins (e.g. amyloid-like aggregates) have been utilized in surface modification of particles, and applications of these modified particles in the field of biomedicine have been also intensively exploited. In this review, the preparation of the above three coatings on particles surface are summarized, and the applications of these materials in drug loading/release, biomineralization, cell immobilization/protection, enzyme immobilization/protection, and antibacterial/antiviral are exemplified. Finally, the challenges and the future research directions on biopolymer coating for particles surface engineering are prospected. This review highlights the importance of particle surface engineering in the materials field. . This review summarizes biopolymer coating for particle surface engineering and their biomedical applications. . This review discusses the key challenges and directions for future research and development of particle surface engineering .
Collapse
|
6
|
Kudryavtseva V, Bukatin A, Vyacheslavova E, Gould D, Sukhorukov GB. Printed asymmetric microcapsules: Facile loading and multiple stimuli-responsiveness. BIOMATERIALS ADVANCES 2022; 136:212762. [PMID: 35929328 DOI: 10.1016/j.bioadv.2022.212762] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 03/08/2022] [Accepted: 03/12/2022] [Indexed: 06/15/2023]
Abstract
Engineering of colloidal particles and capsules despite substantial progress is still facing a number of unsolved issues including low loading capacity, non-uniform size and shape of carriers, tailoring different functionalities and versatility to encapsulated cargo. In this work, we propose a method for defined-shaped functionally asymmetric polymer capsule fabrication based on a soft lithography approach. The developed capsules consist of two classes of polymers - the main part "cup" is made out of polyelectrolyte multilayers (PAH-PSS) and "lid" is made of biodegradable polyether (PLGA). Asymmetric capsules combine advantages from both traditional layer-by-layer capsules and recently developed printed "pelmeni" capsules. This combination provides stimuli-responsiveness due to polyelectrolyte multilayer properties differing from PLGA. The inner volume of capsules can be loaded with a variety of active compounds and the capsule's geometry is defined due to the soft-lithography method. Capsules have a core-shell structure and monodisperse size distribution. Three methods to trigger cargo release have been demonstrated, namely temperature treatment, ultrasonication and pH shift. Steroidal drug dexamethasone was used to illustrate the applicability of the systems for triggered drug release. The application of proposed asymmetric capsules includes but is not limited to pharmacology, diagnostics, sensors, micro- and nanoreactors and chemical actuators.
Collapse
Affiliation(s)
- Valeriya Kudryavtseva
- Nanoforce Technology Ltd, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, United Kingdom; National Research Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russian Federation
| | - Anton Bukatin
- Alferov Saint Petersburg National Research Academic University of the Russian Academy of Sciences, 8/3A Khlopina str, Saint Petersburg 194021, Russia; Institute for Analytical Instrumentation of the Russian Academy of Sciences, 31-33 A, Ivana Chernykh str., Saint Petersburg 198095, Russia
| | - Ekaterina Vyacheslavova
- Alferov Saint Petersburg National Research Academic University of the Russian Academy of Sciences, 8/3A Khlopina str, Saint Petersburg 194021, Russia
| | - David Gould
- Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom
| | - Gleb B Sukhorukov
- Nanoforce Technology Ltd, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, United Kingdom; Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30, bld. 1, Moscow 121205, Russian Federation; Siberian State Medical University, Moskovskiy Trakt, 2, Tomsk 634050, Russia.
| |
Collapse
|
7
|
Kaur H, Ghosh S, Kumar P, Basu B, Nagpal K. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study. Life Sci 2021; 284:119927. [PMID: 34492262 DOI: 10.1016/j.lfs.2021.119927] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2021] [Revised: 08/17/2021] [Accepted: 08/24/2021] [Indexed: 01/23/2023]
Abstract
AIMS Among polyphenolic phytoconstituents with anticancer properties, Ellagic acid (EA) is widely reported for its translational potential in vitro but efficient in vivo delivery of EA has been a challenge. We, for the first time, used a tween 80 coated nano delivery of Ellagic acid to evaluate its preclinical efficacy in vitro and in vivo for breast cancer. MAIN METHODS To overcome the challenges of in vivo delivery, two batches of chitosan-based nanoformulations of EA (with and without tween 80 coating) were prepared by the ionotropic gelation method. The nanoformulations were characterized and further evaluated in vitro against breast cancer cells (MCF7) and in vivo with EAC tumor-bearing mice for establishing their anticancer efficacy compared to Ellagic acid alone. A quantitative simulation study was undertaken to understand if the observed antitumor efficacy is due to the synergistic efficacy of the Chitosan-Ellagic acid combination. KEY FINDINGS Results revealed that nanoformulations consist of good nano-sized encapsulation of EA and showed good drug entrapment-release capacity. Nano-encapsulated EA is biocompatible and exhibited higher cytotoxicity in vitro compared to EA alone. Similarly, significantly higher tumor regression was observed in nano-EA treated mice compared to EA alone, and best efficacy was observed with the nanoformulation with tween 80 coating. Furthermore, nanoformulations showed higher apoptosis in tumor tissues with no significant tissue toxicity in vital organs. SIGNIFICANCE We report synergism of Chitosan-Ellagic acid combination in the tween 80 coated nanoparticles of Ellagic acid resulting in enhanced anti-breast tumor efficacy that may be of translational value for other tumor types, too.
Collapse
Affiliation(s)
- Harsheen Kaur
- Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, AUUP 201303, India
| | - Sandip Ghosh
- Department of Neuroendocrinology & Experimental Hematology, Chittaranjan National Cancer Institute, Kolkata 700026, India
| | - Pradeep Kumar
- Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa
| | - Biswarup Basu
- Department of Neuroendocrinology & Experimental Hematology, Chittaranjan National Cancer Institute, Kolkata 700026, India.
| | - Kalpana Nagpal
- Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, AUUP 201303, India.
| |
Collapse
|
8
|
Villanueva-Flores F, Castro-Lugo A, Ramírez OT, Palomares LA. Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices. NANOTECHNOLOGY 2020; 31:132002. [PMID: 31770746 PMCID: PMC7105107 DOI: 10.1088/1361-6528/ab5bc8] [Citation(s) in RCA: 67] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Revised: 10/28/2019] [Accepted: 11/26/2019] [Indexed: 05/05/2023]
Abstract
Biomedical applications increasingly require fully characterized new nanomaterials. There is strong evidence showing that nanomaterials not only interact with cells passively but also actively, mediating essential molecular processes for the regulation of cellular functions, but we are only starting to understand the mechanisms of those interactions. Systematic studies about cell behavior as a response to specific nanoparticle properties are scarce in the literature even when they are necessary for the rational design of medical nanodevices. Information in the literature shows that the physicochemical properties determine the bioactivity, biocompatibility, and safety of nanomaterials. The information available regarding the interaction and responses of cells to nanomaterials has not been analyzed and discussed in a single document. Hence, in this review, we present the latest advances about cellular responses to nanomaterials and integrate the available information into concrete considerations for the development of innovative, efficient, specific and, more importantly, safe biomedical nanodevices. We focus on how physicochemical nanoparticle properties (size, chemical surface, shape, charge, and topography) influence cell behavior in a first attempt to provide a practical guide for designing medical nanodevices, avoiding common experimental omissions that may lead to data misinterpretation. Finally, we emphasize the importance of the systematic study of nano-bio interactions to acquire sufficient reproducible information that allows accurate control of cell behavior based on tuning of nanomaterial properties. This information is useful to guide the design of specific nanodevices and nanomaterials to elicit desired cell responses, like targeting, drug delivery, cell attachment, differentiation, etc, or to avoid undesired side effects.
Collapse
Affiliation(s)
- Francisca Villanueva-Flores
- Instituto de Biotecnología. Universidad Nacional Autónoma de México. Ave. Universidad 2001. Col. Chamilpa. Cuernavaca, Morelos 62210, México
Villanueva-Flores F: ; Castro-Lugo A: ; Ramírez O: ; Palomares L:
| | - Andrés Castro-Lugo
- Instituto de Biotecnología. Universidad Nacional Autónoma de México. Ave. Universidad 2001. Col. Chamilpa. Cuernavaca, Morelos 62210, México
Villanueva-Flores F: ; Castro-Lugo A: ; Ramírez O: ; Palomares L:
| | - Octavio T Ramírez
- Instituto de Biotecnología. Universidad Nacional Autónoma de México. Ave. Universidad 2001. Col. Chamilpa. Cuernavaca, Morelos 62210, México
Villanueva-Flores F: ; Castro-Lugo A: ; Ramírez O: ; Palomares L:
| | - Laura A Palomares
- Instituto de Biotecnología. Universidad Nacional Autónoma de México. Ave. Universidad 2001. Col. Chamilpa. Cuernavaca, Morelos 62210, México
Villanueva-Flores F: ; Castro-Lugo A: ; Ramírez O: ; Palomares L:
| |
Collapse
|
9
|
Morais AÍS, Vieira EG, Afewerki S, Sousa RB, Honorio LMC, Cambrussi ANCO, Santos JA, Bezerra RDS, Furtini JAO, Silva-Filho EC, Webster TJ, Lobo AO. Fabrication of Polymeric Microparticles by Electrospray: The Impact of Experimental Parameters. J Funct Biomater 2020; 11:jfb11010004. [PMID: 31952157 PMCID: PMC7151563 DOI: 10.3390/jfb11010004] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2019] [Revised: 01/10/2020] [Accepted: 01/10/2020] [Indexed: 02/06/2023] Open
Abstract
Microparticles (MPs) with controlled morphologies and sizes have been investigated by several researchers due to their importance in pharmaceutical, ceramic, cosmetic, and food industries to just name a few. In particular, the electrospray (ES) technique has been shown to be a viable alternative for the development of single particles with different dimensions, multiple layers, and varied morphologies. In order to adjust these properties, it is necessary to optimize different experimental parameters, such as polymer solvent, voltage, flow rate (FR), type of collectors, and distance between the collector and needle tip, which will all be highlighted in this review. Moreover, the influence and contributions of each of these parameters on the design and fabrication of polymeric MPs are described. In addition, the most common configurations of ES systems for this purpose are discussed, for instance, the main configuration of an ES system with monoaxial, coaxial, triaxial, and multi-capillary delivery. Finally, the main types of collectors employed, types of synthesized MPs and their applications specifically in the pharmaceutical and biomedical fields will be emphasized. To date, ES is a promising and versatile technology with numerous excellent applications in the pharmaceutical and biomaterials field and such MPs generated should be employed for the improved treatment of cancer, healing of bone, and other persistent medical problems.
Collapse
Affiliation(s)
- Alan Í. S. Morais
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Ewerton G. Vieira
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Samson Afewerki
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham & Women’s Hospital, Cambridge, MA 02139, USA;
- Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, MIT, Cambridge, MA 02139, USA
| | - Ricardo B. Sousa
- Federal Institute of Education, Science and Technology of Tocantins, Dianápolis Campus, IFTO, Dianápolis 77300-000, Tocantins, Brazil;
| | - Luzia M. C. Honorio
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Anallyne N. C. O. Cambrussi
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Jailson A. Santos
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Roosevelt D. S. Bezerra
- Federal Institute of Education, Science and Technology of Piauí, Teresina-Central Campus, IFPI, Teresina 64000-040, Brazil;
| | - Josy A. O. Furtini
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Edson C. Silva-Filho
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
| | - Thomas J. Webster
- Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA;
| | - Anderson O. Lobo
- LIMAV—Interdisciplinary Advanced Materials Laboratory, PPGCM—Materials Science and Engineering Graduate Program, UFPI—Federal University of Piaui, Teresina 64049-550, Brazil; (A.Í.S.M.); (E.G.V.); (L.M.C.H.); (A.N.C.O.C.); (J.A.S.); (J.A.O.F.); (E.C.S.-F.)
- Correspondence: ; Tel.: +55-86-3237-1057
| |
Collapse
|
10
|
Kim B, Park JH, Sailor MJ. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2019; 31:e1903637. [PMID: 31566258 PMCID: PMC6891135 DOI: 10.1002/adma.201903637] [Citation(s) in RCA: 163] [Impact Index Per Article: 32.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2019] [Revised: 07/12/2019] [Indexed: 05/07/2023]
Abstract
With the recent FDA approval of the first siRNA-derived therapeutic, RNA interference (RNAi)-mediated gene therapy is undergoing a transition from research to the clinical space. The primary obstacle to realization of RNAi therapy has been the delivery of oligonucleotide payloads. Therefore, the main aims is to identify and describe key design features needed for nanoscale vehicles to achieve effective delivery of siRNA-mediated gene silencing agents in vivo. The problem is broken into three elements: 1) protection of siRNA from degradation and clearance; 2) selective homing to target cell types; and 3) cytoplasmic release of the siRNA payload by escaping or bypassing endocytic uptake. The in vitro and in vivo gene silencing efficiency values that have been reported in publications over the past decade are quantitatively summarized by material type (lipid, polymer, metal, mesoporous silica, and porous silicon), and the overall trends in research publication and in clinical translation are discussed to reflect on the direction of the RNAi therapeutics field.
Collapse
Affiliation(s)
- Byungji Kim
- Materials Science and Engineering Program, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA
| | - Ji-Ho Park
- Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea
| | - Michael J Sailor
- Materials Science and Engineering Program, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA
| |
Collapse
|
11
|
Aryal S, Park H, Leary JF, Key J. Top-down fabrication-based nano/microparticles for molecular imaging and drug delivery. Int J Nanomedicine 2019; 14:6631-6644. [PMID: 31695361 PMCID: PMC6707381 DOI: 10.2147/ijn.s212037] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 06/25/2019] [Indexed: 12/17/2022] Open
Abstract
Recent breakthroughs in nanoparticle research have led to improved drug delivery and have overcome problems associated with normal drug delivery methods. Optimizing the design of nanoparticles in terms of controlled size, shape, and surface chemistry of nanoparticles can maximize the therapeutic efficacy. To maximize therapeutic effects, advanced formulation and fabrication methods have been developed. Biomedical applications of nanoparticles produced using the new fabrication techniques, including drug delivery and molecular imaging, have been widely explored. This review highlights the simple and versatile manufacturing techniques that can be used in the development of new types of nanoparticles that have strictly controlled physiochemical properties and their multifaceted advantages in drug delivery and molecular imaging.
Collapse
Affiliation(s)
- Susmita Aryal
- Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do26493, South Korea
| | - Hyungkyu Park
- Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do26493, South Korea
| | - James F Leary
- Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN47906, USA
| | - Jaehong Key
- Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do26493, South Korea
| |
Collapse
|
12
|
Tang T, Weng T, Jia H, Luo S, Xu Y, Li L, Zhang P. Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications. Biomater Sci 2019; 7:715-732. [PMID: 30762040 DOI: 10.1039/c8bm01219a] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The existence of challenging diseases such as cancers, HIV and Zika requires developing new vaccines that can generate tunable and robust immune responses against the diseases. Biomaterials-based techniques have been broadly explored for designing vaccines that can produce controllable and potent immunity. Among the existing biomaterials-based strategies, the layer-by-layer (LbL) assembly technique is remarkably attractive in vaccine design due to its unique features such as programmed and versatile cargo loading, cargo protection, co-delivery, juxtaposing of immune signals, etc. In this work, we reviewed the existing LbL-based vaccine design techniques for translational applications. Specifically, we discussed nanovaccines constructed by coating polyelectrolyte multilayers (PEMs) on nanoparticles, microcapsule vaccines assembled from PEMs, polyplex/complex vaccines condensed from charged materials and microneedle vaccines deposited with PEMs, highlighting the employment of these techniques to promote immunity against diseases ranging from cancers to infectious and autoimmune diseases (i.e., HIV, influenza, multiple sclerosis, etc.). Additionally, the review specifically emphasized using LbL-based vaccine technologies for tuning the cellular and molecular pathways, demonstrating the unique advantages presented by these vaccination strategies. These studies showed the versatility and potency of using LbL-based techniques for designing the next generation of biomaterials vaccines for translational purposes.
Collapse
Affiliation(s)
- Tan Tang
- Department of Material Processing and Controlling, School of Mechanical Engineering & Automation, Beihang University, China.
| | | | | | | | | | | | | |
Collapse
|
13
|
Wauters AC, Pijpers IAB, Mason AF, Williams DS, Tel J, Abdelmohsen LKEA, van Hest JCM. Development of Morphologically Discrete PEG-PDLLA Nanotubes for Precision Nanomedicine. Biomacromolecules 2018; 20:177-183. [PMID: 30265794 PMCID: PMC6335608 DOI: 10.1021/acs.biomac.8b01245] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
![]()
Precise
control over the morphological features of nanoparticles
is an important requisite for their application in nanomedical research.
Parameters such as size and shape have been identified as critical
features for effective nanotherapeutic technologies due to their role
in circulation, distribution, and internalization in vivo. Tubular
PEG–PDLLA polymersomes (nanotubes) exhibit an interesting morphology
with potential for immunotherapeutics, as the elongated shape can
affect cell–particle interactions. Developing methodologies
that permit control over the precise form of such nanotubes is important
for their biomedical implementation due to the stringent physicochemical
constraints for efficacious performance. Through careful control over
the engineering process, we demonstrate the generation of well-defined
nanotubes based on polymersomes as small as 250 and 100 nm, which
can be successfully shape transformed. The quality of the resulting
nanostructures was established by physical characterization using
AF4-MALS and cryo-TEM. Moreover, we show the successful loading of
such nanotubes with model payloads (proteins and drugs). These findings
provide a promising platform for implementation in biomedical applications
in which discrete structure and functionality are essential features.
Collapse
Affiliation(s)
- Annelies C Wauters
- Bio-Organic Chemistry, Institute for Complex Molecular Systems , Eindhoven University of Technology , P.O. Box 513 (STO 3.41), 5600 MB Eindhoven , The Netherlands.,Department of Biomedical Engineering, Laboratory of Immunoengineering , Eindhoven University of Technology , 5600 MB Eindhoven , The Netherlands
| | - Imke A B Pijpers
- Bio-Organic Chemistry, Institute for Complex Molecular Systems , Eindhoven University of Technology , P.O. Box 513 (STO 3.41), 5600 MB Eindhoven , The Netherlands
| | - Alexander F Mason
- Bio-Organic Chemistry, Institute for Complex Molecular Systems , Eindhoven University of Technology , P.O. Box 513 (STO 3.41), 5600 MB Eindhoven , The Netherlands
| | - David S Williams
- Department of Chemistry, College of Science , Swansea University , Swansea , United Kingdom
| | - Jurjen Tel
- Department of Biomedical Engineering, Laboratory of Immunoengineering , Eindhoven University of Technology , 5600 MB Eindhoven , The Netherlands
| | - Loai K E A Abdelmohsen
- Bio-Organic Chemistry, Institute for Complex Molecular Systems , Eindhoven University of Technology , P.O. Box 513 (STO 3.41), 5600 MB Eindhoven , The Netherlands
| | - Jan C M van Hest
- Bio-Organic Chemistry, Institute for Complex Molecular Systems , Eindhoven University of Technology , P.O. Box 513 (STO 3.41), 5600 MB Eindhoven , The Netherlands
| |
Collapse
|